Extracted from this filing and checked against the source text.
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.95
Akari Therapeutics Plc issued 3,125,000 ADSs each representing 2,000 ordinary shares of unit to institutional investors for $0.80 per combined ADS and accompanying warrants, aggregate gross proceeds approximately $2.5 million.
- Security
- unit
- Shares
- 3,125,000 ADSs each representing 2,000 ordinary shares
- Purchaser
- institutional investors
- Consideration
- $0.80 per combined ADS and accompanying warrants, aggregate gross proceeds approximately $2.5 million
Exact text from the filing
E Warrants, the “Warrants”), which are being issued in a concurrent private placement. The combined purchase price per each ADS and accompanying Warrants sold in the Offering is $0.80. The aggregate gross proceeds from the Offering are expected to be approximately $2.5 million, excluding any proceeds from any future exercises of Warrants. The Offering
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.9
Akari Therapeutics Plc issued Placement Agent warrants to purchase up to 125,000 ADSs of warrant to Placement Agent for Issued as compensation for placement agent services; exercise price $1.00 per share; 5-year term.
- Security
- warrant
- Shares
- Placement Agent warrants to purchase up to 125,000 ADSs
- Purchaser
- Placement Agent
- Consideration
- Issued as compensation for placement agent services; exercise price $1.00 per share; 5-year term
Exact text from the filing
The Placement Agent or its designees will also receive warrants (the “Placement Agent Warrants”) on substantially the same terms as the Series E Warrants in an amount equal to 4.0% of the aggregate number of ADSs sold in the Offering, or Placement Agent warrants to purchase up to 125,000 ADSs, at an exercise price of $1.00 per share and will have a 5-year term from the commencement of sales of the Offering.
View on SEC.gov
Equity Issuances
SEC 8-K Item 3.02/3.03
confidence 0.95
Akari Therapeutics Plc issued Series E warrants to purchase up to 3,125,000 ADSs and Series F warrants to purchase up to 3,125,000 ADSs of warrant to institutional investors for Issued as part of unit with ADS at $0.80 per combined unit; exercise price $0.98 per share.
- Security
- warrant
- Shares
- Series E warrants to purchase up to 3,125,000 ADSs and Series F warrants to purchase up to 3,125,000 ADSs
- Purchaser
- institutional investors
- Consideration
- Issued as part of unit with ADS at $0.80 per combined unit; exercise price $0.98 per share
Exact text from the filing
E Warrants, the “Warrants”), which are being issued in a concurrent private placement. The combined purchase price per each ADS and accompanying Warrants sold in the Offering is $0.80. The aggregate gross proceeds from the Offering are expected to be approximately $2.5 million, excluding any proceeds from any future exercises of Warrants. The Offering
View on SEC.gov